1. Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial. (January 2023) Authors: Shipa, Muhammad; Santos, Liliana R; Nguyen, Dao X; Embleton-Thirsk, Andrew; Parvaz, Mariea; Heptinstall, Lauren L; Pepper, Ruth J; Isenberg, David A; Gordon, Caroline; Ehrenstein, Michael R Journal: Lancet Issue: Volume 5:Number 1(2023) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. (October 2019) Authors: Embleton-Thirsk, Andrew; Deane, Elizabeth; Townsend, Stephen; Farrelly, Laura; Popoola, Babasola; Parker, Judith; Rustin, Gordon; Sydes, Matthew; Parmar, Mahesh; Ledermann, Jonathan; Kaplan, Richard Journal: Clinical trials Issue: Volume 16:Number 5(2019) Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O07 The increase in erythrocyte mean corpuscular volume by methotrexate is potentiated by hydroxychloroquine and is an early indicator of clinical response in rheumatoid arthritis. (26th April 2021) Authors: Shipa, Muhammad R; Yeoh, Su-Ann; Embleton-Thirsk, Andrew; Mukerjee, Dev; Ehrenstein, Michael R Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume. (4th May 2021) Authors: Shipa, Muhammad Ruhul Amin; Yeoh, Su-Ann; Embleton-Thirsk, Andrew; Mukerjee, Dev; Ehrenstein, Michael R Journal: Rheumatology Issue: Volume 61:Number 2(2022) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗